NCT04176575: Balancing Method for Pain Related to Advanced Cancer

NCT04176575
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: 
Exclusions: Patients with acupuncture experience within the prior 3 months
https://ClinicalTrials.gov/show/NCT04176575

Comments are closed.

Up ↑